CAF	Cancer-associate fibroblast
CCND1	Cyclin D1
CDKN2A	Cyclin-dependent kinase inhibitor 2A
CXCL1	C-X-C motif chemokine ligand 1
DFS	Disease-free survival
DNA	Deoxyribonucleic acid
EGF	Epidermal growth factor
EGFR	Epidermal growth factor receptor
EMA	European medicines agency
EMT-TF	EMT transcription factor
EMT	Epithelial-to-mesenchymal transition
EpCAM	Epithelial cell adhesion molecule
EPIC	Estimating the proportion of immune and cancer cells
EZH2	Enhancer of zeste 2
FDA	Food and drug administration
FHCC	Fred Hutchinson cancer center
GLI1	Glioma-associated oncogene 1
GSEA	Gene set enrichment analysis
HIF1α	Hypoxia-induced factor 1 alpha
HNSCC	Head and neck squamous cell carcinoma
HPV	Human papillomavirus
IL	Interleukin
ITH	Intra- and intertumoral heterogeneity
Malat1	Metastasis-associated lung adenocarcinoma transcript 1
MATH	Mutant allele tumor heterogeneity
MDACC	MD Anderson cancer center
miRNA	MicroRNA
MMP	Matrix metalloproteinase
MRD	Minimal residual disease
MTD	Maximal tolerable dose
MYC	Myc oncogene (Myelocytomatosis oncogene homolog)
NPC	Nasopharyngeal carcinoma
OS	Overall survival
OSCC	Oral squamous cell carcinoma
P53	Tumor protein P53
PD-L1	Programmed death ligand 1
PD1	Programmed cell death protein 1
pEMT	Partial EMT
PI3KCA	Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
PRRX1	Paired-related homeobox 1
R(C)T	Radio(chemo)therapy
RNA	Ribonucleic acid
SCC	Squamous cell carcinoma
scRNAseq	Single cell RNA sequencing
SMAD	Sma and Mad protein homologs
TCGA	The cancer genome atlas
TGFβ	Transforming growth factor beta
TGFβR	Transforming growth factor beta receptor
WNT	Wingless integrated
ZEB	Zinc finger E-box-binding homeobox protein